 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|
   |
| RXMD Continues Fight Against Opioid Abuse and Attracts More Media Coverage |
|
 Hot Stock to Watch |
Company: Progressive Care Inc. (OTCQB: RXMD)
|
Last:
Price: 0.0715
Change (%): - 0.0085 (10.62)
Volume: 576,181 |
 |
Progressive Care Inc. Speaks About Alternative Medicine to Combat the Opioid Crisis
Company Secured Media Coverage in Insider Financial and Cannabis Radio Show
MIAMI, Feb. 04, 2019 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has garnered media coverage in Insider Financial and Cannabis Radio Show as one of the top plays for investors looking to make money off the opioid crisis in the U.S. and using alternative medicine to combat the crisis.
“I am honored to be recognized in Insider Financial and Cannabis Talk A to Z regarding the opioid crisis, something I am so passionate about fighting,” said S. Parikh Mars, CEO of Progressive Care Inc. “Progressive Care strives to put patients first by offering the best alternatives to opioid medications and by making the process to attain these medicines seamless and affordable.”
In an article titled Progressive Care Inc (OTCMKTS:RXMD): A Top Play on Opioid Crisis, published on January 14, 2019, Insider Financial discussed how Progressive Care is in an ongoing fight for non-opioid treatments for pain to be routinely covered by insurance. Today, insurance companies are restricting benefits to the point where a patient can no longer get coverage for outpatient pain management solutions other than prescription grade ibuprofen, or Tylenol.
Continue Reading
|
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
